Delivery Order SPE2DB25D3001-SPE2DB25FQVBL
- Not listed
- The Defense Logistics Agency awarded a $2,015.65 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, on August 8, 2025, with completion expected by August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger relationship with the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 18, 2025, with completion targeted for August 19, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under a competitive procurement process. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,663.27 for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with performance to be executed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,580.59 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication used within military and federal healthcare systems. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $3,333.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,550.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 19, 2025, with completion scheduled for August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $5,044.48. This firm fixed-price delivery order, which is set to be completed by July 30, 2025, represents a pediatric diabetes medication procurement for federal healthcare systems. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $4,281.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 21, 2025, with completion expected by July 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,466.03 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed price delivery order represents a pediatric diabetes medication supply for military healthcare systems. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens on August 19, 2025, with completion expected by August 20, 2025. This competitive award, issued without set-aside designation, utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical...
- SPE2DB25D3001Indefinite Delivery Contract
- SPE2DB25D3001-SPE2DB25FQVBLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,222.19 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order represents a pediatric diabetes medication procurement supporting federal healthcare requirements. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that authorizes the company to supply pharmaceutical products and medical supplies globally to support military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical federal contractor supplying an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers. The company's established position within DLA's pharmaceutical supply chain, demonstrated through numerous competitively awarded contracts, positions it as a key vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/11/25 |